| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3999628 | Urologic Oncology: Seminars and Original Investigations | 2015 | 6 Pages |
Abstract
BCR for patients with CSM at RP is tantamount to PSM patients. CSM <1Â mm should be explicitly noted on pathology reports. Patients with this finding should be followed up closely and offered adjuvant therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Michael J. M.D., Edan Y. M.D., Michael B. M.D., Andrew T. M.D., Solomon L. M.D., Arindam Ph.D., Trushar M.D., Ketan K. M.D.,